Page 138 - 第10期
P. 138

第41卷第10期
               ·1556 ·                           南 京    医 科 大 学 学         报                        2021年10月


              径发挥效应。但目前大部分实验只局限于动物和                                  scription and splicing[J]. Nature,2016,539(7629):
              细胞,尚未运用到临床,需要进行大规模的临床研                                 452-455
              究,以观察 lncRNA⁃miRNA⁃mRNA 轴的调节能否做                   [14] BARWARI T,JOSHI A,MAYR M. MicroRNAs in cardio⁃
                                                                     vascular disease[J]. J Am Coll Cardiol,2016,68(23):
              为药物治疗的靶点或作为疾病进展的标志物,最终
                                                                     2577-2584
              将ncRNA运用于临床实践。
                                                                [15] 孟   荔,史爱武. 微小 RNA 在心血管疾病中的研究进
             [参考文献]                                                  展[J]. 南京医科大学学报(自然科学版),2018,38(4):
                                                                     562-568
             [1] TRIPOSKIADIS F,XANTHOPOULOS A,BUTLER J.
                   Cardiovascular aging and heart failure:JACC review top⁃  [16] BALLANTYNE M D,MCDONALD R A,BAKER A H. ln⁃
                   ic of the week[J]. J Am Coll Cardiol,2019,74(6):804-  cRNA/MicroRNA interactions in the vasculature[J]. Clin
                   813                                               Pharmacol Ther,2016,99(5):494-501
             [2] BENJAMIN E J,BLAHA M J,CHIUVE S E,et al. Heart  [17] LIANG H,ZHANG J,ZEN K,et al. Nuclear microRNAs
                   disease and stroke statistics⁃ 2017 update:a report from  and their unconventional role in regulating non ⁃ coding
                   the American Heart Association[J]. Circulation,2017,  RNAs[J]. Protein Cell,2013,4(5):325-330
                   135(10):e146-e603                            [18] EBERT M S,NEILSON J R,SHARP P A. MicroRNA
             [3] KAIKKONEN M U,ADELMAN K. Emerging roles of non⁃     sponges:competitive inhibitors of small RNAs in mamma⁃
                   coding RNA transcription[J]. Trends Biochem Sci,2018,  lian cells[J]. Nat Methods,2007,4(9):721-726
                   43(9):654-667                                [19] QU J,LI M,ZHONG W,et al. Competing endogenous
             [4] ANASTASIADOU E,JACOB L S,SLACK F J. Non⁃cod⁃        RNA in cancer:a new pattern of gene expression regula⁃
                   ing RNA networks in cancer[J]. Nat Rev Cancer,2018,  tion[J]. Int J Clin Exp Med,2015,8(10):17110-17116
                   18(1):5-18                                   [20] WANG F,YANG H,DENG Z,et al. HOX antisense lin⁃
             [5] LIU S,YANG Y,JIANG S,et al. Understanding the role  cRNA HOXA⁃AS2 promotes tumorigenesis of hepatocellu⁃
                   of non⁃coding RNA(ncRNA)in stent restenosis[J]. Ath⁃  lar carcinoma[J]. Cell Physiol Biochem,2016,40(1/2):
                   erosclerosis,2018,272:153-161                     287-296
             [6] SALLAM T,SANDHU J,TONTONOZ P. Long noncoding   [21] XU S,KAMATO D,LITTLE P J,et al. Targeting epi⁃
                   RNA discovery in cardiovascular disease:decoding form  genetics and non ⁃ coding RNAs in atherosclerosis:from
                   to function[J]. Circ Res,2018,122(1):155-166      mechanisms to therapeutics[J]. Pharmacol Ther,2019,
             [7] ZHANG Y,DU W,YANG B. Long non⁃coding RNAs as        196:15-43
                   new regulators of cardiac electrophysiology and arrhyth⁃  [22] GIMBRONE M A,GARCÍA ⁃ CARDEÑA G. Endothelial
                   mias:molecular mechanisms,therapeutic implications  cell dysfunction and the pathobiology of atherosclerosis
                   and challenges[J]. Pharmacol Ther,2019,203:107389  [J]. Circ Res,2016,118(4):620-636
             [8] CARRIERI C,CIMATTI L,BIAGIOLI M,et al. Long non⁃  [23] BASATEMUR G L,JØRGENSEN H F,CLARKE M C H,
                   coding antisense RNA controls Uchl1 translation through  et al. Vascular smooth muscle cells in atherosclerosis[J].
                   an embedded SINEB2 repeat[J]. Nature,2012,491     Nat Rev Cardiol,2019,16(12):727-744
                  (7424):454-457                                [24] BOON R A,JAÉ N,HOLDT L,et al. Long noncoding
             [9] SALMENA L,POLISENO L,TAY Y,et al. A CeRNA hy⁃       RNAs:from clinical genetics to therapeutic targets?[J]. J
                   pothesis:the Rosetta stone of a hidden RNA language?  Am Coll Cardiol,2016,67(10):1214-1226
                  [J]. Cell,2011,146(3):353-358                 [25] THUM T,CONDORELLI G. Long noncoding RNAs and
             [10] DYKES I M,EMANUELI C. Transcriptional and post ⁃   microRNAs in cardiovascular pathophysiology[J]. Circ
                   transcriptional gene regulation by long non⁃coding RNA  Res,2015,116(4):751-762
                  [J]. Genomics Proteomics Bioinformatics,2017,15(3):  [26] STEINBERG D,WITZTUM J L. Oxidized low⁃density li⁃
                   177-186                                           poprotein and atherosclerosis[J]. Arterioscler Thromb
             [11] JÉGU T,AEBY E,LEE J T. The X chromosome in space   Vasc Biol,2010,30(12):2311-2316
                  [J]. Nat Rev Genet,2017,18(6):377-389         [27] LI S,SUN Y,ZHONG L,et al. The suppression of ox⁃LDL⁃
             [12] WANG F,CHAINANI P,WHITE T,et al. Deep learning     induced inflammatory cytokine release and apoptosis of
                   identifies genome⁃wide DNA binding sites of long noncod⁃  HCAECs by long non⁃coding RNA⁃MALAT1 via regulat⁃
                   ing RNAs[J]. RNA Biol,2018,15(12):1468-1476       ing microRNA⁃155/SOCS1 pathway[J]. Nutr Metab Car⁃
             [13] ENGREITZ J M,HAINES J E,PEREZ E M,et al. Local     diovasc Dis,2018,28(11):1175-1187
                   regulation of gene expression by lncRNA promoters,tran⁃  [28] LI M N,QIAN M,KYLER K,et al. Endothelial⁃vascular
   133   134   135   136   137   138   139   140   141   142   143